CClinicalTrials.gg
CompletedNCT06361134Updated Apr 11, 2024

Efficacy of Supporting SAFE Early Intervention

An interventional study of SAFE Early İntervention and NDT based therapy in Infant Development, Physiotherapy and Early Intervention, sponsored by Gazi University. Completed at 1 site in Turkey. Open to participants aged 1 Month to 3 Months. Per ClinicalTrials.gov, last updated 2024-04-11.

Sponsored by Gazi University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Jan 2021, registered Mar 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
1 Month to 3 Months
Sex
All
01

Study summary

Within the scope of the study, it was planned that risky babies would be treated with the SAFE early intervention approach for 10 weeks after they were discharged from the intensive care unit. Neurodevelopmental Treatment was applied to the control group. Sensory, motor and language development of the babies were evaluated before and after the intervention.

02

Conditions studied

  • Infant Development
  • Physiotherapy
  • Early Intervention
03

In context

Lead sponsor

Gazi University is the lead sponsor of 531 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 3 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Neurologically and developmentally risky infant (such as premature birth, hypoxia, infection, hypoxic ischemic encephalopathy),

Having a NICU history of 15 days or more,

Exclusion criteria

Exclusion Criteria:

congenital malformations, metabolic and genetic disease musculoskeletal system anomaly

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    SAFE Early Intervention Group

    A sensory-based, activity-focused early intervention program was implemented in an enriched environment (SAFE Early intervention). Children in the intervention group received home visits once a month and their families were coached. Families were informed about how to support their children. Home visits were made once a month for 10 weeks.

    Behavioral: SAFE Early İntervention · Behavioral: NDT based therapy

  • Experimental
    Control Group

    Home-based NDT program was applied to the control group. The babies in the group were examined in a clinic environment and the families were given booklets to support their children's development.

    Behavioral: SAFE Early İntervention · Behavioral: NDT based therapy

Interventions

  • BehavioralSAFE Early İntervention

    As part of the intervention, sensory-based intervention was applied in an enriched environment. In the home setting, physiotherapists collaborated with the family to advance the intervention. The intervention was revised by making monthly home visits to infants with a corrected age of 42 weeks.

  • BehavioralNDT based therapy

    Neuromotor evaluations of the babies were performed in a clinical setting. The rehabilitation program to be implemented was given to the family as a booklet. The programs of the children examined in the clinic every month were revised.

06

What researchers measure

Primary outcomes

  1. Test of Infant Motor Profile

    High numerical scores indicate that infants notice and respond to stimuli less than their peers, meaning the infant is hypersensitive, while low numerical scores indicate that infants notice and respond to stimuli more than their peers, or are hypersensitive.

    Time frame: 10 weeks

Secondary outcomes

  1. Bayley Scales of Infant and Toddler Development, Third Edition,

    Bayley Scales of Infant and Toddler Development- III is the most widely used tool for assessment of early development.Bayley-III including Cognitive, Language, and Motor scales . "1" if the child meets the scoring criteria for each item; If the child does not meet the criteria, he receives a score of "0". Raw scores for each subtest are summed (Total Raw Score) and then converted to scale scores, composite scores, percentile ranks and confidence intervals using the tables provided in the manual. These scores are used to determine the child's performance compared to norms from typically developing children their age (in months).

    Time frame: 10 weeks

  2. Infant/Toddler Sensory Profile 2

    The Infant/Toddler Sensory Profile (ITSP) was developed in response to the need for a standardized assessment of sensory processing for infants and toddlers. The ITSP is a caregiver questionnaire designed to measure in-fant/toddler responses to various sensory stimuli. It has two age bands: birth to6 (0-6) months and 7 to 36 (7-36) months, with 36 and 48 items, respectively. Each itemon the ITSP describes a certain behavior that may occur in daily life, with the fre-quency of such behaviors rated by the caregiver on a five-point Likert scale (1=always, 2=frequently, 3=occasionally, 4=seldom, and 5=never).

    Time frame: 10 weeks

  3. Infant/Toddler HOME Inventory

    It is used to evaluate children's home environment. It evaluates the home environment of children aged 0-3 under six different subheadings. Parents rate the frequency of the child's behavior on a five-point scale from 1 (almost always) to 5 (almost never). The items in this test are; It evaluates six different areas: general, auditory, visual, tactile, vestibular and oral sensory processing. A higher score indicates that the answer occurs less frequently

    Time frame: 10 weeks

07

Study locations

1 site
  • Erzurum Technical University
    Erzurum, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06361134
Lead sponsor
Gazi University
Responsible party
Ayse Simsek (Gazi University, Gazi University) — Principal investigator
First posted
Apr 11, 2024
Start date
Jan 15, 2021
Primary completion
May 15, 2022
Completion
Nov 15, 2022
Last update
Apr 11, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion